Huntsman Corporation (HUN) Stock Price & How to Invest

Huntsman Corporation is a global manufacturer of differentiated and specialty chemicals organized into three segments: Polyurethanes (MDI, polyols and TPU used in insulation, automotive seating, adhesives, coatings and footwear), Performance Products (amines, surfactants and maleic anhydride for agriculture, energy, personal care and construction), and Advanced Materials (epoxy, phenoxy, acrylic and polyurethane formulations for aerospace, electronics and industrial uses). It is roughly the fourth-largest MDI producer worldwide, behind Wanhua Chemical, BASF and Covestro.

The investment picture is defined by a deep chemicals downcycle and a pending combination. Full-year 2025 revenue fell to about $5.7 billion with a net loss of roughly $275 million, and Q1 2026 stayed in the red as MDI margins, weak construction and automotive demand, and Chinese low-cost capacity pressured results. Net debt leverage climbed to about 6.1x, the dividend was cut, and credit ratings were lowered to below investment grade. In June 2026 Huntsman agreed to merge with Olin in an all-stock deal, so the shares now trade heavily on the exchange ratio, deal completion odds and expected synergies rather than standalone fundamentals alone.

Huntsman is deeply cyclical and was loss-making in 2025 and early 2026, with net debt leverage around 6.1x and credit ratings cut to below investment grade, so a prolonged downturn strains the balance sheet. The dividend was reduced sharply and is not guaranteed. The Olin merger introduces deal risk: it requires shareholder and regulatory approvals and could be delayed or blocked, and because it is all-stock the value received depends on Olin's share price. Low-cost Chinese MDI capacity, weak construction and automotive demand, and volatile feedstock costs such as benzene and European natural gas can all pressure margins further.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Huntsman Corporation's investor relations page or your broker.

• Revenue (FY2025): ~$5.7B
• Revenue (Q1 2026): ~$1.42B
• Net loss (FY2025): ~$275M
• Diluted EPS (FY2025): ~-$1.59
• Market cap: ~$1.8-2.4B
• Net debt leverage: ~6.1x

Huntsman is currently unprofitable on a trailing basis, so a positive P/E is not meaningful and investors lean on revenue, EBITDA and leverage. As of mid-2026 the stock traded around $10 to $11 with a 52-week range of roughly $7.30 to $16, and the dividend yield screened high partly because the price had fallen. With a merger agreed, valuation is best read against the Olin exchange ratio rather than standalone multiples.

There are three common ways to get HUN exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so HUN sits alongside other stocks that express the same thesis.

Walnut takes the basket route. Describe a thesis where HUN fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

HUN is a downcycle industrial-chemicals name whose story is dominated by its pending all-stock merger with Olin, so its price tracks both deal terms and a weak polyurethanes market.

Whether HUN is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is HUN a buy?, and where the stock could go from here in the HUN stock forecast.

For income investors, whether HUN pays a dividend and how the payout looks is covered in does HUN pay a dividend?